Results 91 to 100 of about 3,788,205 (194)

Histopathology of epithelial ovarian cancer cases.

, 2013
Histopathology of epithelial ovarian cancer cases.
Thomas Sellers (302515), Y. Ann Chen (251526), Hector Arango (302511), James P. LaPolla (302513), Lorelei Davis (302507), Ashley D. Molina (302509), Rebecca Sutphen (238390), Gang Han (127634), Santo V. Nicosia (137055), Mitchell S. Hoffman (302514), Weiwei Zhu (251527), Tyler Kirby (302516), Lian Shan (302505)   +12 more
core   +1 more source

Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition

Journal of Translational Medicine
Background Cartilage oligomeric matrix protein (COMP), an extracellular matrix glycoprotein, is vital in preserving cartilage integrity. Further, its overexpression is associated with the aggressiveness of several types of solid cancers.
Gilar Gorji-Bahri, B. Madhu Krishna, Catharina Hagerling, Akira Orimo, Karin Jirström, Konstantinos S. Papadakos, Anna M. Blom   +6 more
doaj   +1 more source

Epithelial ovarian cancer

, 2021
Epithelial ovarian cancer (EOC) refers to a group of ovarian, tubal or peritoneal cancers with different etiology, histology, molecular profile, microenvironment and biological behavior. Despite this heterogeneity, all patients with EOC are treated similarly.
openaire   +2 more sources

Impact of PARP inhibitors on progression-free survival in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective analysis

World Journal of Surgical Oncology
Objective Poly (ADP-ribose) polymerase (PARP) inhibitors such as olaparib and niraparib have shown promise in extending progression-free survival (PFS) in patients with platinum-sensitive recurrent (PSR) epithelial ovarian cancer.
Yumei Zhou, Junfen Xu
doaj   +1 more source

Downregulation of INPP4B is Associated with Poor Prognosis in Epithelial Ovarian Carcinoma

International Journal of General Medicine
Liangliang Jiang, Jing Wang Department of Gynecological Tumor, Harbin Medical University Cancer Hospital, Harbin, People’s Republic of ChinaCorrespondence: Jing Wang, Department of Gynecological Tumor, Harbin Medical University Cancer Hospital, Harbin ...
Jiang L, Wang J
doaj  

Tumour-Stroma Ratio and Platinum Resistance in Epithelial Ovarian Cancer: An Exploratory Analysis. [PDF]

Cancers (Basel)
Gül G, Kutlu Ö, Ayaz D, Günenç D, Özdemir Ö, Akdemir C, Sancı M.   +6 more
europepmc   +1 more source

A study of the predictive value of morphometric assessments in clinical outcome in ovarian epithelial malignancy [PDF]

Quantitative pathology as a tool in gynaecological pathology is fairly new. Such techniques allow greater objectivity than histological grading, typing, and residual tumour estimation.
Palmer, Julia Elizabeth
core  

Histotype and molecular subtype integration in epithelial ovarian cancer: implications for targeted treatment. [PDF]

Cancer Metastasis Rev
Liu S, Sun C.
europepmc   +1 more source

CDS2 Drives Tumor Progression in Epithelial Ovarian Cancer via the PI3K/AKT Pathway. [PDF]

Cancer Med
Cao L, Chen Y, Liu Y, Yang C, Zhang Z, Lin Y, Wang Y, Chen S, Yu F, Ye H, Wu S.   +10 more
europepmc   +1 more source

Mechanisms of resistance to PARP inhibitors in advanced epithelial ovarian cancer: biological determinants and therapeutic implications. [PDF]

Front Oncol
Incognito D, Ciappina G, Ettore G, Ettore C, Incognito GG, Carroccio P, Esposito E, D'Arienzo A, Barraco C, Donato M, Cianci S, Busà B, Di Mauro G, Berretta M.   +13 more
europepmc   +1 more source